SINOCELLTECH GROUP LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.8 CNY | +4.23% |
|
+26.45% | -13.12% |
| Apr. 18 | Sinocelltech Forecasts Return to Profit in Q1 | MT |
| Apr. 18 | China stocks track Asian markets higher | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Sinocelltech Group Ltd is a China-based company mainly engaged in the research, development and industrialization of biopharmaceutical products. The Company focuses on monoclonal antibodies, recombinant proteins and vaccine products. Its main products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000 and SCT630, among others. The Company is also engaged in asset leasing business and payment collection business.
Calendar
2024-04-23
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
46.8
CNY
Average target price
64
CNY
Spread / Average Target
+36.75%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.12% | 2.76B | |
| -0.49% | 103B | |
| +3.31% | 96.73B | |
| +1.66% | 21.31B | |
| -16.16% | 21.21B | |
| -6.82% | 18.79B | |
| -41.41% | 16.37B | |
| -22.87% | 13.68B | |
| +6.32% | 13.44B | |
| +21.46% | 10.98B |
- Stock Market
- Equities
- 688520 Stock
- News Sinocelltech Group Limited
- Sinocelltech Raises $67 Million From Share Placement
